Cytodyn Correlations
| CYDY Stock | USD 0.19 0.01 5.56% |
The correlation of Cytodyn is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cytodyn moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cytodyn moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cytodyn. Also, note that the market value of any OTC Stock could be tightly coupled with the direction of predictive economic indicators such as signals in employment. Cytodyn |
The ability to find closely correlated positions to Cytodyn could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cytodyn when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cytodyn - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cytodyn to buy it.
Moving together with Cytodyn OTC Stock
| + | 0.92 | GLABF | Gemina Laboratories | PairCorr | ||
| + | 0.73 | ZTLLF | Zonetail | PairCorr | ||
| + | 0.66 | NSFDF | NXT Energy Solutions | PairCorr | ||
| + | 0.8 | MCD | McDonalds | Report 30th of October 2023 | PairCorr | |
| + | 0.71 | AA | Alcoa Corp | Report 18th of October 2023 | PairCorr |
Moving against Cytodyn OTC Stock
| - | 0.83 | IBM | International Business | Report 18th of October 2023 | PairCorr | |
| - | 0.8 | CAT | Caterpillar | Report 26th of October 2023 | PairCorr | |
| - | 0.6 | CSCO | Cisco Systems | Fiscal Quarter End 31st of October 2023 | PairCorr | |
| - | 0.51 | GE | General Electric | Report 24th of October 2023 | PairCorr | |
| - | 0.49 | DD | Dupont De Nemours | Report 14th of November 2023 | PairCorr | |
| - | 0.41 | INTC | Intel | Aggressive Push | PairCorr |
Related Correlations Analysis
BKRKF | BKRKY | PPERY | PPERF | TLK | TLKMF | EC | PBCRF | PBCRY | VZ | ||
BKRKF | 0.55 | -0.23 | -0.22 | 0.27 | 0.21 | -0.32 | 0.48 | 0.37 | -0.05 | BKRKF | |
BKRKY | 0.55 | -0.18 | -0.15 | 0.27 | 0.16 | -0.57 | 0.69 | 0.83 | 0.02 | BKRKY | |
PPERY | -0.23 | -0.18 | 0.9 | -0.86 | -0.82 | 0.8 | -0.3 | -0.27 | -0.58 | PPERY | |
PPERF | -0.22 | -0.15 | 0.9 | -0.71 | -0.73 | 0.7 | -0.24 | -0.19 | -0.42 | PPERF | |
TLK | 0.27 | 0.27 | -0.86 | -0.71 | 0.85 | -0.76 | 0.38 | 0.47 | 0.67 | TLK | |
TLKMF | 0.21 | 0.16 | -0.82 | -0.73 | 0.85 | -0.62 | 0.32 | 0.26 | 0.47 | TLKMF | |
EC | -0.32 | -0.57 | 0.8 | 0.7 | -0.76 | -0.62 | -0.51 | -0.67 | -0.5 | EC | |
PBCRF | 0.48 | 0.69 | -0.3 | -0.24 | 0.38 | 0.32 | -0.51 | 0.66 | 0.13 | PBCRF | |
PBCRY | 0.37 | 0.83 | -0.27 | -0.19 | 0.47 | 0.26 | -0.67 | 0.66 | 0.26 | PBCRY | |
VZ | -0.05 | 0.02 | -0.58 | -0.42 | 0.67 | 0.47 | -0.5 | 0.13 | 0.26 | VZ | |
BKRKF | BKRKY | PPERY | PPERF | TLK | TLKMF | EC | PBCRF | PBCRY | VZ |
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations | High negative correlations |
Risk-Adjusted Indicators
There is a big difference between Cytodyn OTC Stock performing well and Cytodyn OTC Stock doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Cytodyn's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Information Ratio | Expected Shortfall | Potential Upside | Value At@Risk | Maximum Drawdown | |
|---|---|---|---|---|---|---|---|---|---|---|
| BKRKF | 1.21 | 0.06 | 0.02 | (3.12) | 1.81 | 0.038 | (4.51) | 5.71 | (5.41) | 14.22 |
| BKRKY | 0.99 | (0.08) | 0.00 | (0.12) | 0.00 | (0.06) | 0.00 | 2.01 | (2.64) | 5.27 |
| PPERY | 0.93 | 0.18 | 0.16 | 0.26 | 1.08 | 0.16 | (1.07) | 1.87 | (2.30) | 6.03 |
| PPERF | 1.97 | 0.19 | 0.05 | 0.13 | 2.12 | 0.06 | (3.99) | 5.56 | (5.00) | 13.24 |
| TLK | 0.72 | (0.14) | 0.00 | (0.43) | 0.00 | (0.11) | 0.00 | 1.28 | (1.28) | 5.56 |
| TLKMF | 0.71 | (0.12) | 0.00 | 0.91 | 0.00 | (0.0435) | 0.00 | 0.00 | (4.00) | 12.70 |
| EC | 1.23 | 0.33 | 0.17 | 0.17 | 1.60 | 0.19 | (1.27) | 2.55 | (2.74) | 7.76 |
| PBCRF | 1.97 | (0.10) | 0.00 | (1.20) | 0.00 | (0.0254) | 0.00 | 3.51 | (5.08) | 15.03 |
| PBCRY | 0.89 | (0.13) | 0.00 | (0.55) | 0.00 | (0.09) | 0.00 | 1.93 | (1.98) | 6.37 |
| VZ | 0.95 | (0.14) | 0.00 | (0.23) | 0.00 | (0.09) | 0.00 | 1.46 | (1.91) | 8.05 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Cytodyn without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Price Exposure Probability Now
Price Exposure ProbabilityAnalyze equity upside and downside potential for a given time horizon across multiple markets |
| All Next | Launch Module |
Cytodyn Corporate Directors
Cytodyn corporate directors refer to members of a Cytodyn board of directors. The board of directors generally takes responsibility for the Cytodyn's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Cytodyn's board members must vote for the resolution. The Cytodyn board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Carl Dockery | Director | Profile | |
| Bruce Montgomery | Independent Director | Profile | |
| David Welch | Director | Profile | |
| Jordan Naydenov | Independent Director | Profile |
Already Invested in Cytodyn?
The danger of trading Cytodyn is mainly related to its market volatility and OTC Stock specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Cytodyn is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Cytodyn. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Cytodyn is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cytodyn. Also, note that the market value of any OTC Stock could be tightly coupled with the direction of predictive economic indicators such as signals in employment. Note that the Cytodyn information on this page should be used as a complementary analysis to other Cytodyn's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Complementary Tools for Cytodyn OTC Stock analysis
When running Cytodyn's price analysis, check to measure Cytodyn's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cytodyn is operating at the current time. Most of Cytodyn's value examination focuses on studying past and present price action to predict the probability of Cytodyn's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cytodyn's price. Additionally, you may evaluate how the addition of Cytodyn to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |